Privately held neurotherapeutics company founded in March 2013 by J.P. Pearson and E.J. Martinez and operated in Cambridge Massachusetts USA. Sea Pharmaceuticals LLC conducts research, development, and-commercialization (R-&-D-&-C) of Sea's novel proprietary synthetic small molecules targeting glutamate neurotransmitter system in neurology disorders. Sea is advancing orally administered potential treatments for high need constant bothersome tinnitus (CBT), Epilepsy, and sporadic Amyotrophic Lateral Sclerosis (S-ALS). Sea has 1 emeritus board member EBM & 7 board members. Benjamin F Cravatt PhD is Sea’s emeritus board member. Ben is neurochemist/ biologist Professor Scripps Research Institute and member NAS (USA National Academy Sciences); Ben founded >10 biotech co’s ActivX, Abide / Lundbeck, Vividion /Bayer, et al.; Sea's 7 board members: (i) Eric R Olson PhD molecular biologist, pharmacologist, trustee Cystic Fibrosis Foundation CFF; drug maker led R-&-D-&-C at Vertex VRTX to 4 life-saving CF drugs Kalydeco, Orkambi, Symdeco, Trikafta; former Aurora/ Vertex, Syros, Upjohn, Warner-Lambert/ Parke-Davis; (ii) Mark G Currie PhD molecular pharmacologist; on board IRWD; former CSO, President Ironwood Pharma Inc; Cyclerion Inc, Sepracor, Monsanto; Mark led R-&-D-&-C teams to drugs Celebrex, Bextra, Deramaxx (veterinary), Dynastat (Europe/Asia), Lunesta, Xopenex, Linzess / Constella (EU); (iii) W. Kendall Brown JD Cal-Tech trained physicist; lawyer Brown Associates Des Moines Iowa; computer scientist Advanced Logic Systems; IBM, California, (iv) Michael J Higgins MBA on several boards; was COO CFO Ironwood / Microbia; VP Genzyme, VP Procept); (v) Shaker Sadasivam PhD, MBA engineer formerly CEO Sun Edison Semi -Conductor (SEMI) Monsanto; on boards several co.; (vi) Nabil Elkouh PhD engineer, metals / batteries expert, CEO Conamix; Erigo Tech LLC, American Titanium Works (ATW); (vii) James P Pearson, President & CEO, Sea. See more at https://www.seapharmaceuticals.com
Company Details
- Employees
- 9
- Founded
- -
- Address
- Cambridge, Massachusetts 02138, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- neurotherapeutic molecules research and development, privately held United States limited liability company, tinnitus therapeutics research and development, epilepsy therapeutics research and development, amyotrophic lateral sclerosis R&D, sporadic ALS research and development, neurology, central nervous system CNS disorders, neuropsychiatry, neuroscience, synthetic organic discovery chemistry, potential new medicines for high medical need CNS disorders, constant bothersome tinnitus, tinnitus, ALS therapeutics R&D.
- HQ
- Cambridge, Massachusetts
Sea Pharmaceuticals Llc Questions
Sea Pharmaceuticals Llc's website is https://www.seapharmaceuticals.com
Sea Pharmaceuticals Llc's LinkedIn profile is https://www.linkedin.com/company/sea-pharmaceuticals
Sea Pharmaceuticals Llc has
9 employees.
View email and phone details for 9
employees at Sea Pharmaceuticals Llc.
Sea Pharmaceuticals Llc's industry is
Pharmaceutical Manufacturing
Sea Pharmaceuticals Llc's top competitors are
Libone,
Unipharma Syria,
Seafarma World Wide Medical Supplier,
Barakat Pharmaceutical Industries,
Alenmaa Pharma Libya (Apseco) شركة الإنماء للأدوية,
Sama Al Andalus,
Zein Pharma Pharmaceutical Industries,
Seapharma, Llc,
Ultra Medica Pharmaceutical Industries,
Oubari Pharma.
Sea Pharmaceuticals Llc's categories are Pharmaceutical Manufacturing
Sea Pharmaceuticals Llc's founding year is 2013
